📊 MIXED Capital Southwest grew portfolio to $2.1B, delivered 40% ROE in FY2026

Revenue & Profitability

Total investment income for Q4 FY2026 was $57.8 million, down from $61.4 million in the prior quarter. Pre-tax net investment income was $35.2 million or $0.59 per share. For the full fiscal year, investment income grew 14% from $204 million to $232 million. NAV per share stood at $16.69, slightly down from $16.75 in the prior quarter. The company declared $0.64 per share in total dividends for the June 2026 quarter ($0.58 regular + $0.06 supplemental). Undistributed taxable income (UTI) was $1.07 per share.

Outlook

Management views the lower middle market as resilient, driven by founder-related catalysts (retirement, succession) that are less sensitive to macro volatility. Deal flow increased to an annual run rate of ~1,400 deals reviewed, but the close rate moderated to 1.5% due to disciplined pricing. Macro headwinds mentioned include the 'Liberation Day' event, private credit contagion, and the conflict in Iran, but these have not dampened activity in the company's core market.

Growth Drivers

Growth is fueled by add-on financings (31% of new commitments over the last 12 months), new platform investments (13 new sponsors in FY2026), and the expansion of the CapTrin Partners JV. The company added two Managing Directors and a strengthened portfolio operations group. The ATM equity program raised $160 million in FY2026 at 1.3x NAV, providing accretive capital for portfolio growth. The JV is expected to produce 13%-14% returns once fully ramped in 18-24 months.

Balance Sheet & CapEx

Not discussed in this earnings call as a separate line item. However, the company invested in human capital, growing from 27 to 36 employees (and another seven planned), and raised $465 million in new debt capital commitments ($350 million bond, $90 million SBIC II leverage, $25 million secured debt). Additionally, the CapTrin JV closed a $150 million revolving credit facility post-quarter end.

Margins

Operating leverage improved from 1.7% in the prior quarter to 1.4% at Q4 FY2026, despite adding six employees. Management expects to maintain operating leverage between 1.4%-1.5% going forward. Cost of compensation is approximately $5.5 million per quarter. The lower leverage is attributed to over-accruals reversing and strong fee income. The internally managed model provides structural efficiency versus the industry median of 2.7%.

Key Risks

Risks flagged include macro disruptions (Liberation Day, private credit contagion, Iran conflict) that could impact market multiples and portfolio valuations. One portfolio company was added to the watch list with a write-down, and overall market multiple compression affected unrealized appreciation. Dividend income from equity co-investments may decline if portfolio companies are sold. Dividend sustainability depends on continued realized gains and UTI coverage.

Generated by AI · Q4 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q1 2027 Q1 2027 2026-08-04

Pre-tax net investment income was $0.57 per share, with total investment income rising to $61 million and strong portfolio growth. The board declared $0.64 per share in dividends, and liquidity remains robust. Shareholder approval is sought for increased authorized shares.

Q4 2026 Q4 2026 2026-05-14

Investment portfolio and income grew strongly year-over-year, with robust credit quality and steady dividend increases. Significant capital was raised, and major equity realizations are expected soon, supporting future distributions.

Q3 2026 Q3 2026 2026-02-03

Pre-tax net investment income rose to $0.60 per share, with strong recurring earnings and robust UTI. Portfolio growth, conservative leverage, and a new JV support continued dividend coverage and future deal flow. Spreads are expected to remain stable near 7%.

Q2 2026 Q2 2026 2025-11-04

Pre-tax net investment income was $0.61 per share, with strong origination activity and robust liquidity. Portfolio quality remains high, with 91% rated in the top two categories and only 1% on non-accrual. New capital raised extends debt maturities and supports continued growth.

Q1 2026 Q1 2026 2025-08-07

Pre-tax net investment income rose to $32.7M, with improved non-accruals and robust dividend coverage. Portfolio growth and strong liquidity support continued originations, while competitive pressures compress spreads. Conservative leverage and capital allocation remain priorities.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.